Poltreg Alternatives & Competitors
12 companies similar to Poltreg — Harnessing groundbreaking TREG therapy for global health innovation.
Companies similar to Poltreg
Adenosine Therapeutics
Pioneering Innovation in Cardiac Stress Diagnostics
T3 Pharmaceuticals AG
Developing the next generation bacterial cancer therapy
BigDNA
Pioneering Next-Generation Vaccination Solutions for a Healthier Future
Rival Readout
Competing with Poltreg? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Micrima Limited
Redefining Cancer Diagnostics
UNeMed Corporation
Tech transfer & commercialization for the University of Nebraska Medical Center and the Un...
EraCal Therapeutics
Towards an efficacious and well-tolerated appetite-suppressant using our innovative in-viv...
InVenis Biotherapies
Platelet-derived Regenerative Therapy for CNS Disorders
Argonaut Therapeutics
Argonaut Therapeutics uses PRMT5 inhibitors and companion diagnostics for precision cancer...
About Poltreg
Poltreg is a biotechnology startup that harnesses groundbreaking TREG therapy for global health innovation. Originating as a spin-off from the Medical University of Gdańsk, the company is dedicated to developing and commercializing the patented TREG method. With promising results from clinical trials at the University...
Medical Innovation, Clinical Trials, TREG Therapy, University Spin-off, Research Commercialization, Patent Licensing, Medical Research, University Collaboration, Startup Funding, Innovation Management
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Poltreg: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Poltreg on 12 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.